- Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
-
de Medeiros LPJ, Lima MB, Pires MM, Maciel AM, Medeiros R, Donadel MD, Pereira IM, Leão FM, Pires LE, Rzetelna H, Brandão-Mello CE
- KMID: 2413256
- Osong Public Health Res Perspect.
- 2018 Apr;9(2):50-58.
- doi: 10.24171/j.phrp.2018.9.2.03
OBJECTIVES: To evaluate the impact of 3 treatment regimens upon health-related quality of life and work productivity using patient-reported outcomes (PROs) in chronic hepatitis C infected patients: sofosbuvir (SOF) +... -
- CITED
-
- Close
- SHARE
-
- Close
